Skip to content
HowShorted

CorMedix Inc. short interest in 2018

In 2018, CorMedix Inc.'s disclosed short interest ran from 6.46% of shares outstanding on 12 Jan 2018 to 13.15% on 31 Dec 2018, a change of +6.69 percentage points. The year's high was 13.61% on 14 Dec 2018 and its low 6.46% on 12 Jan 2018, averaging 9.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.86 days on 15 May 2018. Full history: CorMedix Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CorMedix Inc. in 2018

2018 in figures

Start of year
6.46% (12 Jan 2018)
End of year
13.15% (31 Dec 2018)
Change
+6.69 pp
High
13.61% (14 Dec 2018)
Low
6.46% (12 Jan 2018)
Average
9.18%
Highest days to cover
12.86 (15 May 2018)
SEC filings marked
8

Every report in 2018

CorMedix Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20186.46%5.19
31 Jan 20187.00%7.20
15 Feb 20186.98%4.89
28 Feb 20187.34%1.20
15 Mar 20187.30%3.08
29 Mar 20187.22%2.3810-K filed, results (8-K)
13 Apr 20188.12%3.58
30 Apr 20188.30%10.84
15 May 20187.98%12.8610-Q filed, results (8-K)
31 May 20187.86%5.39
15 Jun 20188.82%2.25
29 Jun 20188.35%4.20
13 Jul 20188.00%6.05
31 Jul 201810.17%1.05
15 Aug 20188.86%1.8510-Q filed, results (8-K)
31 Aug 20188.26%2.36
14 Sep 20188.32%4.11
28 Sep 20188.84%2.85
15 Oct 201813.29%1.58
31 Oct 201811.76%3.00
15 Nov 201811.73%4.6510-Q filed, results (8-K)
30 Nov 201812.65%5.25
14 Dec 201813.61%4.26
31 Dec 201813.15%8.02

See also: CorMedix Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.